4//SEC Filing
Garrett Gerald 4
Accession 0001209191-20-018528
CIK 0001094038other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:36 PM ET
Size
8.3 KB
Accession
0001209191-20-018528
Insider Transaction Report
Form 4
Garrett Gerald
Vice President, Clinical Ops.
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-03-10+1,700→ 1,700 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (1,700 underlying) - Award
Employee Stock Option (Right to Buy)
2020-03-10+38,300→ 38,300 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (38,300 underlying)
Footnotes (2)
- [F1]Represents a bonus for 2019 performance granted under the Company's 2014 Omnibus Stock Ownership Plan. This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
- [F2]This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001804510
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 4:36 PM ET
- Size
- 8.3 KB